Related references
Note: Only part of the references are listed.In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-κB and Activation of Caspase-8
Ian E. Gentle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TNFα-induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2
Joo-Young Kim et al.
JOURNAL OF CELL SCIENCE (2011)
Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury
Kiyohiko Hotta et al.
KIDNEY INTERNATIONAL (2011)
Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis
Jianxin Lu et al.
NEPHROLOGY (2011)
Genetic Ablation of TWEAK Augments Regeneration and Post-Injury Growth of Skeletal Muscle in Mice
Ashwani Mittel et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
A. W. R. van Kuijk et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Tumor Necrosis Factor (TNF) Signaling, but Not TWEAK (TNF-like Weak Inducer of Apoptosis)-triggered cIAP1 (Cellular Inhibitor of Apoptosis Protein 1) Degradation, Requires cIAP1 RING Dimerization and E2 Binding
Rebecca Feltham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
Ashwani Mittal et al.
JOURNAL OF CELL BIOLOGY (2010)
Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway
Claudia Roos et al.
JOURNAL OF IMMUNOLOGY (2010)
The CD163-expressing macrophages recognize and internalize TWEAK Potential consequences in atherosclerosis
Juan A. Moreno et al.
ATHEROSCLEROSIS (2009)
TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling
A. Wicovsky et al.
CELL DEATH AND DIFFERENTIATION (2009)
TWEAK/Fn14 Pathway: A Nonredundant Role in Intestinal Damage in Mice Through a TWEAK/Intestinal Epithelial Cell Axis
Taeko Dohi et al.
GASTROENTEROLOGY (2009)
Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand
Agnes Wyzgol et al.
JOURNAL OF IMMUNOLOGY (2009)
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα
James E. Vince et al.
JOURNAL OF CELL BIOLOGY (2008)
The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity
Amanda L. Willis et al.
MOLECULAR CANCER RESEARCH (2008)
The TWEAK - Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting
Jeffrey A. Winkles
NATURE REVIEWS DRUG DISCOVERY (2008)
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L
D. Berg et al.
CELL DEATH AND DIFFERENTIATION (2007)
A previously unrecognized protein-protein interaction between TWEAK and CD163:: Potential biological implications
Laura C. Bover et al.
JOURNAL OF IMMUNOLOGY (2007)
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration
Mahasweta Girgenrath et al.
EMBO JOURNAL (2006)
Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis
Koichi Kamata et al.
JOURNAL OF IMMUNOLOGY (2006)
TWEAK is a novel arthritogenic mediator
Stuart J. Perper et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein
C Dogra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells
Takashi Ando et al.
ARTHRITIS RESEARCH & THERAPY (2006)
TWEAK attenuates the transition from innate to adaptive immunity
H Maecker et al.
CELL (2005)
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis
S Desplat-Jégo et al.
CLINICAL IMMUNOLOGY (2005)
TWEAK induces liver progenitor cell proliferation
A Jakubowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo
BA Tannous et al.
MOLECULAR THERAPY (2005)
Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis
AM Mueller et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration
I Potrovita et al.
JOURNAL OF NEUROSCIENCE (2004)
Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis
T Kawakita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death
M Nakayama et al.
JOURNAL OF IMMUNOLOGY (2003)
Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis
CA Wilson et al.
CELL DEATH AND DIFFERENTIATION (2002)
TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity
S Desplat-Jégo et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Multiple pathways of TWEAK-Induced cell death
M Nakayama et al.
JOURNAL OF IMMUNOLOGY (2002)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity
M Nakayama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas
SLY Feng et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
